ScripThe news that Poolbeg Pharma is exploring a possible merger with Hookipa Pharma that would see the firm move its listing from London to the NASDAQ has excited their prospective boards but not gone dow
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol Looks Into Tolerizing Vaccines,